HighPoint Advisor Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,523
| Closed | -$712K | – | 817 |
|
|
2025
Q4 | $712K | Sell |
14,523
-370
| -2% | -$17.3K | 0.02% | 570 |
|
|
2025
Q3 | $643K | Buy |
14,893
+415
| +3% | +$16.2K | 0.03% | 339 |
|
|
2025
Q2 | $556K | Buy |
14,478
+2,431
| +20% | +$92.9K | 0.03% | 351 |
|
|
2025
Q1 | $469K | Buy |
12,047
+2,899
| +32% | +$106K | 0.03% | 371 |
|
|
2024
Q4 | $330K | Sell |
9,148
-1
| -0% | -$36 | 0.02% | 477 |
|
|
2024
Q3 | $374K | Sell |
9,149
-1,210
| -12% | -$49.5K | 0.02% | 428 |
|
|
2024
Q2 | $412K | Buy |
10,359
+704
| +7% | +$29.6K | 0.02% | 392 |
|
|
2024
Q1 | $436K | Sell |
9,655
-1,162
| -11% | -$47.9K | 0.03% | 384 |
|
|
2023
Q4 | $463K | Buy |
+10,817
| New | +$388K | 0.03% | 370 |
|
|
2022
Q2 | $607K | Buy |
+11,267
| New | +$622K | 0.07% | 243 |
|
|
2021
Q3 | $583K | Sell |
12,204
-177
| -1% | -$8.89K | 0.06% | 277 |
|
|
2021
Q2 | $616K | Buy |
12,381
+1,238
| +11% | +$59.5K | 0.06% | 262 |
|
|
2021
Q1 | $510K | Sell |
11,143
-505
| -4% | -$22.9K | 0.06% | 262 |
|
|
2020
Q4 | $521K | Sell |
11,648
-279,655
| -96% | -$12.8M | 0.06% | 248 |
|
|
2020
Q3 | $625K | Sell |
291,303
-1,907
| -0.7% | -$95.5K | 0.11% | 148 |
|
|
2020
Q2 | $782K | Sell |
293,210
-4,983
| -2% | -$256K | 0.17% | 112 |
|
|
2020
Q1 | $1.07M | Buy |
298,193
+6,223
| +2% | +$332K | 0.25% | 80 |
|
|
2019
Q4 | $875K | Sell |
291,970
-268
| -0.1% | -$14.9K | 0.18% | 100 |
|
|
2019
Q3 | $807K | Buy |
292,238
+239,923
| +459% | +$12.3M | 0.18% | 106 |
|
|
2019
Q2 | $650K | Buy |
52,315
+39,393
| +305% | +$1.98M | 0.15% | 116 |
|
|
2019
Q1 | $639K | Sell |
12,922
-53
| -0.4% | -$2.65K | 0.16% | 132 |
|
|
2018
Q4 | $669K | Sell |
12,975
-119
| -0.9% | -$5.86K | 0.18% | 129 |
|
|
2018
Q3 | $663K | Buy |
13,094
+430
| +3% | +$21.8K | 0.18% | 135 |
|
|
2018
Q2 | $646K | Sell |
12,664
-113
| -0.9% | -$5.69K | 0.17% | 147 |
|
|
2018
Q1 | $655K | Sell |
12,777
-796
| -6% | -$37.1K | 0.18% | 145 |
|
|
2017
Q4 | $620K | Buy |
13,573
+185
| +1% | +$8.55K | 0.18% | 141 |
|
|
2017
Q3 | $602K | Buy |
13,388
+1,218
| +10% | +$61.8K | 0.19% | 144 |
|
|
2017
Q2 | $617K | Hold |
12,170
| – | – | 0.2% | 136 |
|
|
2017
Q1 | $617K | Buy |
12,170
+1,408
| +13% | +$71.4K | 0.2% | 136 |
|
|
2016
Q4 | $557K | Sell |
10,762
-1,131
| -10% | -$55.9K | 0.18% | 155 |
|
|
2016
Q3 | $571K | Sell |
11,893
-321
| -3% | -$17.6K | 0.2% | 130 |
|
|
2016
Q2 | $678K | Buy |
12,214
+2,977
| +32% | +$157K | 0.24% | 108 |
|
|
2016
Q1 | $497K | Sell |
9,237
-1,839
| -17% | -$91.6K | 0.3% | 98 |
|
|
2015
Q4 | $554K | Sell |
11,076
-977
| -8% | -$49.8K | 0.36% | 87 |
|
|
2015
Q3 | $579K | Sell |
12,053
-416
| -3% | -$21.7K | 0.64% | 63 |
|
|
2015
Q2 | $649K | Buy |
12,469
+1,120
| +10% | +$63.1K | 1% | 43 |
|
|
2015
Q1 | $670K | Buy |
+11,349
| New | +$651K | 1.02% | 43 |
|
Other funds holding GSK
JEST
HighPoint Advisor Group's GSK Position: Q1 2026 in Review
HighPoint Advisor Group sold out of GSK (GSK) in Q1 2026, closing a stake of 14,523 shares — an estimated $712K sold.
HighPoint Advisor Group first reported a position in GSK in Q1 2015 and held it in 37 quarters. The position peaked at $1.07M in Q1 2020. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- HighPoint Advisor Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
- HighPoint Advisor Group sold 14,523 GSK shares in Q1 2026, an estimated $712K.
- HighPoint Advisor Group first reported a position in GSK in Q1 2015 and held it in 37 quarters.
- HighPoint Advisor Group's GSK position peaked at $1.07M in Q1 2020.
- 1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.